Aytu BioPharma, Inc.
Aytu BioPharma, Inc. (AYTU) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001385818 · AYTU · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001385818 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Aytu BioPharma, Inc. (NASDAQ: AYTU) has submitted 893 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Healthcare sector company with CIK 0001385818, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Aytu BioPharma, Inc.'s most comprehensive regulatory disclosure. The most recent Aytu BioPharma, Inc. 10-K was filed on 2025-09-23 for fiscal year ending 2025. Historical AYTU 10-K annual reports are available from 2007 through 2025.
Investors researching Aytu BioPharma, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
AYTU SEC Filings · 8 questionsAytu BioPharma, Inc. (AYTU) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 893 filings and access original documents at no cost. Aytu BioPharma, Inc.'s CIK is 0001385818.